Clinical Trials on Refractory in France

Total 293 results

Gustave Roussy, Cancer Campus, Grand Paris

Completed

Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

Malignant Tumors | Refractory Tumors

France
Nantes University Hospital

Withdrawn

Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL (RITEPRALL)

CD22+ Relapsed/Refractory B-ALL

France
Groupe Hospitalier Paris Saint Joseph

Completed

Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites (BEVASCITE)

Refractory Malignant Ascites

France
Centre Hospitalier Universitaire de Nice

Completed

Pilot Study of Sedation With Propofol in Refractory Pains Due to Care in Palliative Care Unit (PROPOPAL1)

Refractory Pains | End of Life Patients

France
University Hospital, Strasbourg, France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors (RAPIRI)

Refractory Solid Tumors in Children

France
Gilead Sciences

Completed

Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies

Relapsed/Refractory B-cell Malignancies

France, United Kingdom
Association for Training, Education, and Research...

Active, not recruiting

Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders (LY-SET-HAPLO)

Refractory or Relapsed Lymphoid Haemopathy

France
Hospices Civils de Lyon

Completed

Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon) (PERLYON)

Refractory Epilepsy

France
Assistance Publique - Hôpitaux de Paris

Unknown

Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics (ARAM)

Refractory Ascites in Patients With Cirrhosis

France
Elsan

Recruiting

Transcranial Direct-current Stimulation (tDCS) Efficacy in Refractory Cancer Pain. (STIMPAL)

Cancer Pain | Refractory Pain

France
Gustave Roussy, Cancer Campus, Grand Paris
Innovative Therapies For Children with Cancer Consortium

Unknown

Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling (MAPPYACTS)

Relapsed or Refractory Pediatric Tumor

France, Ireland, Israel, Italy, Spain
University Hospital, Montpellier

Recruiting

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Intractable Epilepsy

Refractory Epilepsy

France
University Hospital, Montpellier
Centre Hospitalier Universitaire de Nīmes; Institut du Cancer de Montpellier; Oncopole Toulouse

Completed

Intrathecal Analgesia Effects on Cancer Patients Discomfort Symptoms (IT-ESAS)

Refractory Cancer Pain | Intrathecal Analgesia

France
University Hospital, Bordeaux
Novartis; National Cancer Institute, France; Fondation ARC

Recruiting

Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults (SPARTO)

Refractory or Recurrent Solid Tumor

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; International...

Terminated

Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)

Depression

France
Assistance Publique Hopitaux De Marseille

Withdrawn

Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy

Refractory Epilepsy

France
Central Hospital, Nancy, France
Inserm U954 - N-GERE (Nutrition, Genetics and Exposition to Environmental...

Unknown

High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE) (MYRAGE)

High-risk Myelodysplastic Syndromes With Excess Blasts

France
Association for Training, Education, and Research...

Completed

Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia (SET-HAPLO)

Refractory Acute Myeloid Leukemia

France
The Lymphoma Academic Research Organisation

Active, not recruiting

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

Refractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell Lymphoma

France
Centre Leon Berard
NETRIS Pharma

Recruiting

Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] (AML-NET)

Acute Myeloid Leukemia Refractory

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies (PerEpi2)

Epilepsy | Children | tDCS | Transcranial Electric Stimulation | Pharmacoresistant | HR EEG

France
Hopital of Melun

Not yet recruiting

Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus (I-Seizure)

Refractory Status Epilepticus

France
The Lymphoma Academic Research Organisation
Lymphoma Study Association

Not yet recruiting

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Refractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Lymphoma

France
Centre Hospitalier Universitaire de Nice

Active, not recruiting

Combined Cingulate and Thalamic DBS for Chronic Refractory Chronic Pain (EMOPAIN)

Chronic Refractory Neuropathic Pain

France
University Hospital, Toulouse
MSD France

Active, not recruiting

COllaboration REsearch on Chronic Cough (COREC): a French Multicenter Database (COREC)

Refractory Chronic Cough

France
University Hospital, Grenoble

Recruiting

Atlas of Human Cognition by SEEG (MAPCOG-SEEG) (MAPCOG-SEEG)

Focal Epilepsy | Refractory Epilepsy

France
Brian Jonas
Pharmacyclics LLC.

Completed

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Refractory Anemia With Excess Blasts in Transformation

United States
University Hospital, Grenoble

Completed

Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018 (AQUA)

Refractory Cardiac Arrest | ExtraCorporeal Membrane Oxygenation (ECMO)

France
Sequana Medical N.V.

Completed

ALFApump System Versus Standard of Care in Ascites Treatment

Refractory or Recurrent Ascites

Spain, United Kingdom, Italy, France, Austria
Assistance Publique Hopitaux De Marseille

Unknown

Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery (Hyporadoul)

Any Cancer With Multiple Bone Metastases

France
University Hospital, Toulouse
Dixi Medical; Centre de recherche Cerveau et Cognition (CERCO)

Recruiting

Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy (NENUFAR)

Epilepsy

France
European Society for Blood and Marrow Transplantation
EULAR

Withdrawn

Autologous Stem Cell Transplantation: International Lupus Trial (ASTIL)

REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

France
University Hospital, Strasbourg, France

Completed

Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.

Refractory Frontal Lobe Epilepsy

France
MaaT Pharma

Recruiting

Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013 (ORION)

Steroid Refractory GVHD | Intestinal GVHD

France
Institut Cancerologie de l'Ouest
Esteve

Recruiting

OP2C : Prialt® Observatory in Clinical Practice (OP2C)

Refractory Pain

France
Hospices Civils de Lyon

Completed

Levosimendan for Veno-arterial ECMO Weaning (WEANECMO)

Cardiogenic Shock | Refractory Shock

France
Onconova Therapeutics, Inc.

Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess Blasts

United States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
Cemka-Eval
Boston Scientific Corporation

Completed

Follow-up of Post-spinal Implantable Neurostimulator PRECISION® (PRECISION)

Chronic Refractory Neuropathic Pain | Ischemic Peripheral Pain

France
Nantes University Hospital

Completed

Multi-centric Study (CHEPRALL)

B ALL | CD22+ Expression | Refractory B-ALL

France
Onconova Therapeutics, Inc.

Terminated

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)

Myelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEB

United States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
European Society for Blood and Marrow Transplantation
Mallinckrodt

Completed

ECP Combination Study

Steroid Refractory GVHD

Spain, United Kingdom, Sweden, Italy, Israel, France, Denmark, Germany, Poland, Turkey, Romania, Belgium, Greece, Russian Federation
Centre Hospitalier Universitaire de Nice

Recruiting

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma (CART-Omic)

Refractory or Relapsed Non-Hodgkin's Lymphoma

France
University Hospital, Bordeaux

Terminated

A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection (BOTOX-TME)

Low Anterior Resection Syndrome (LARS>20) | Refractory Medical Treatment After Rectal Resection

France
Centre hospitalier de Ville-Evrard, France

Recruiting

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia (TDCSHALLU)

Schizophrenia | Hallucinations | Refractory Schizophrenia

France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic Leukemia

United Kingdom, Spain, France, Australia
Institut Hospitalo-Universitaire Méditerranée Infection
University Hospital, Marseille

Unknown

Rhinosinusites Chroniques

Sinusitis | Chronic Disease | Refractory

France
Central Hospital, Nancy, France

Completed

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction (177Lumen)

Refractory Meningioma

France
University Hospital, Brest
Teva Pharmaceuticals USA

Terminated

Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine. (MYLY)

Cerebral Lymphoma B Cell Refractory

France
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) (E7080-G000-231)

Relapsed or Refractory Solid Tumors

United States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
Janssen Research & Development, LLC

Completed

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Relapsed or Refractory Hodgkin Lymphoma

France, Germany

Clinical Trials on Refractory in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations